Global Infliximab Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Infliximab Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Infliximab Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infliximab Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infliximab Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infliximab Biosimilar total production and demand, 2018-2029, (K Units)
Global Infliximab Biosimilar total production value, 2018-2029, (USD Million)
Global Infliximab Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Infliximab Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Infliximab Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Infliximab Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Infliximab Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Infliximab Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Infliximab Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Napp Pharmaceuticals Group, Janssen Biotech, Alvogen, Merck, Celltrion, Pfizer(Ac Hospira) and Nippon Kayaku, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infliximab Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Infliximab Biosimilar Market, By Region:
1. How big is the global Infliximab Biosimilar market?
2. What is the demand of the global Infliximab Biosimilar market?
3. What is the year over year growth of the global Infliximab Biosimilar market?
4. What is the production and production value of the global Infliximab Biosimilar market?
5. Who are the key producers in the global Infliximab Biosimilar market?
6. What are the growth factors driving the market demand?
This report studies the global Infliximab Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infliximab Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infliximab Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infliximab Biosimilar total production and demand, 2018-2029, (K Units)
Global Infliximab Biosimilar total production value, 2018-2029, (USD Million)
Global Infliximab Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Infliximab Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Infliximab Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Infliximab Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Infliximab Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Infliximab Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Infliximab Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Napp Pharmaceuticals Group, Janssen Biotech, Alvogen, Merck, Celltrion, Pfizer(Ac Hospira) and Nippon Kayaku, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infliximab Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Infliximab Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CT-P13/infliximab-dyyb
- Remsima
- Inflectra
- Crohn's Disease
- Rheumatoid Arthritis
- Ulcerative Colitis
- Ankylosing Spondylitis
- Plaque Psoriasis
- Others
- Napp Pharmaceuticals Group
- Janssen Biotech
- Alvogen
- Merck
- Celltrion
- Pfizer(Ac Hospira)
- Nippon Kayaku
1. How big is the global Infliximab Biosimilar market?
2. What is the demand of the global Infliximab Biosimilar market?
3. What is the year over year growth of the global Infliximab Biosimilar market?
4. What is the production and production value of the global Infliximab Biosimilar market?
5. Who are the key producers in the global Infliximab Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Infliximab Biosimilar Introduction
1.2 World Infliximab Biosimilar Supply & Forecast
1.2.1 World Infliximab Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Infliximab Biosimilar Production (2018-2029)
1.2.3 World Infliximab Biosimilar Pricing Trends (2018-2029)
1.3 World Infliximab Biosimilar Production by Region (Based on Production Site)
1.3.1 World Infliximab Biosimilar Production Value by Region (2018-2029)
1.3.2 World Infliximab Biosimilar Production by Region (2018-2029)
1.3.3 World Infliximab Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Infliximab Biosimilar Production (2018-2029)
1.3.5 Europe Infliximab Biosimilar Production (2018-2029)
1.3.6 China Infliximab Biosimilar Production (2018-2029)
1.3.7 Japan Infliximab Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infliximab Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infliximab Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Infliximab Biosimilar Demand (2018-2029)
2.2 World Infliximab Biosimilar Consumption by Region
2.2.1 World Infliximab Biosimilar Consumption by Region (2018-2023)
2.2.2 World Infliximab Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Infliximab Biosimilar Consumption (2018-2029)
2.4 China Infliximab Biosimilar Consumption (2018-2029)
2.5 Europe Infliximab Biosimilar Consumption (2018-2029)
2.6 Japan Infliximab Biosimilar Consumption (2018-2029)
2.7 South Korea Infliximab Biosimilar Consumption (2018-2029)
2.8 ASEAN Infliximab Biosimilar Consumption (2018-2029)
2.9 India Infliximab Biosimilar Consumption (2018-2029)
3 WORLD INFLIXIMAB BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infliximab Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Infliximab Biosimilar Production by Manufacturer (2018-2023)
3.3 World Infliximab Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Infliximab Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infliximab Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infliximab Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Infliximab Biosimilar in 2022
3.6 Infliximab Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Infliximab Biosimilar Market: Region Footprint
3.6.2 Infliximab Biosimilar Market: Company Product Type Footprint
3.6.3 Infliximab Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infliximab Biosimilar Production Value Comparison
4.1.1 United States VS China: Infliximab Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Infliximab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Infliximab Biosimilar Production Comparison
4.2.1 United States VS China: Infliximab Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Infliximab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Infliximab Biosimilar Consumption Comparison
4.3.1 United States VS China: Infliximab Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Infliximab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Infliximab Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Infliximab Biosimilar Production (2018-2023)
4.5 China Based Infliximab Biosimilar Manufacturers and Market Share
4.5.1 China Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Infliximab Biosimilar Production (2018-2023)
4.6 Rest of World Based Infliximab Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Infliximab Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Infliximab Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CT-P13/infliximab-dyyb
5.2.2 Remsima
5.2.3 Inflectra
5.3 Market Segment by Type
5.3.1 World Infliximab Biosimilar Production by Type (2018-2029)
5.3.2 World Infliximab Biosimilar Production Value by Type (2018-2029)
5.3.3 World Infliximab Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infliximab Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Crohn's Disease
6.2.2 Rheumatoid Arthritis
6.2.3 Ulcerative Colitis
6.2.4 Ankylosing Spondylitis
6.2.5 Plaque Psoriasis
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Infliximab Biosimilar Production by Application (2018-2029)
6.3.2 World Infliximab Biosimilar Production Value by Application (2018-2029)
6.3.3 World Infliximab Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Napp Pharmaceuticals Group
7.1.1 Napp Pharmaceuticals Group Details
7.1.2 Napp Pharmaceuticals Group Major Business
7.1.3 Napp Pharmaceuticals Group Infliximab Biosimilar Product and Services
7.1.4 Napp Pharmaceuticals Group Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Napp Pharmaceuticals Group Recent Developments/Updates
7.1.6 Napp Pharmaceuticals Group Competitive Strengths & Weaknesses
7.2 Janssen Biotech
7.2.1 Janssen Biotech Details
7.2.2 Janssen Biotech Major Business
7.2.3 Janssen Biotech Infliximab Biosimilar Product and Services
7.2.4 Janssen Biotech Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Janssen Biotech Recent Developments/Updates
7.2.6 Janssen Biotech Competitive Strengths & Weaknesses
7.3 Alvogen
7.3.1 Alvogen Details
7.3.2 Alvogen Major Business
7.3.3 Alvogen Infliximab Biosimilar Product and Services
7.3.4 Alvogen Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Alvogen Recent Developments/Updates
7.3.6 Alvogen Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Infliximab Biosimilar Product and Services
7.4.4 Merck Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Celltrion
7.5.1 Celltrion Details
7.5.2 Celltrion Major Business
7.5.3 Celltrion Infliximab Biosimilar Product and Services
7.5.4 Celltrion Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Celltrion Recent Developments/Updates
7.5.6 Celltrion Competitive Strengths & Weaknesses
7.6 Pfizer(Ac Hospira)
7.6.1 Pfizer(Ac Hospira) Details
7.6.2 Pfizer(Ac Hospira) Major Business
7.6.3 Pfizer(Ac Hospira) Infliximab Biosimilar Product and Services
7.6.4 Pfizer(Ac Hospira) Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer(Ac Hospira) Recent Developments/Updates
7.6.6 Pfizer(Ac Hospira) Competitive Strengths & Weaknesses
7.7 Nippon Kayaku
7.7.1 Nippon Kayaku Details
7.7.2 Nippon Kayaku Major Business
7.7.3 Nippon Kayaku Infliximab Biosimilar Product and Services
7.7.4 Nippon Kayaku Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Nippon Kayaku Recent Developments/Updates
7.7.6 Nippon Kayaku Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Infliximab Biosimilar Industry Chain
8.2 Infliximab Biosimilar Upstream Analysis
8.2.1 Infliximab Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Infliximab Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Infliximab Biosimilar Production Mode
8.6 Infliximab Biosimilar Procurement Model
8.7 Infliximab Biosimilar Industry Sales Model and Sales Channels
8.7.1 Infliximab Biosimilar Sales Model
8.7.2 Infliximab Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Infliximab Biosimilar Introduction
1.2 World Infliximab Biosimilar Supply & Forecast
1.2.1 World Infliximab Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Infliximab Biosimilar Production (2018-2029)
1.2.3 World Infliximab Biosimilar Pricing Trends (2018-2029)
1.3 World Infliximab Biosimilar Production by Region (Based on Production Site)
1.3.1 World Infliximab Biosimilar Production Value by Region (2018-2029)
1.3.2 World Infliximab Biosimilar Production by Region (2018-2029)
1.3.3 World Infliximab Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Infliximab Biosimilar Production (2018-2029)
1.3.5 Europe Infliximab Biosimilar Production (2018-2029)
1.3.6 China Infliximab Biosimilar Production (2018-2029)
1.3.7 Japan Infliximab Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infliximab Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infliximab Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Infliximab Biosimilar Demand (2018-2029)
2.2 World Infliximab Biosimilar Consumption by Region
2.2.1 World Infliximab Biosimilar Consumption by Region (2018-2023)
2.2.2 World Infliximab Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Infliximab Biosimilar Consumption (2018-2029)
2.4 China Infliximab Biosimilar Consumption (2018-2029)
2.5 Europe Infliximab Biosimilar Consumption (2018-2029)
2.6 Japan Infliximab Biosimilar Consumption (2018-2029)
2.7 South Korea Infliximab Biosimilar Consumption (2018-2029)
2.8 ASEAN Infliximab Biosimilar Consumption (2018-2029)
2.9 India Infliximab Biosimilar Consumption (2018-2029)
3 WORLD INFLIXIMAB BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infliximab Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Infliximab Biosimilar Production by Manufacturer (2018-2023)
3.3 World Infliximab Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Infliximab Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infliximab Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infliximab Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Infliximab Biosimilar in 2022
3.6 Infliximab Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Infliximab Biosimilar Market: Region Footprint
3.6.2 Infliximab Biosimilar Market: Company Product Type Footprint
3.6.3 Infliximab Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infliximab Biosimilar Production Value Comparison
4.1.1 United States VS China: Infliximab Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Infliximab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Infliximab Biosimilar Production Comparison
4.2.1 United States VS China: Infliximab Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Infliximab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Infliximab Biosimilar Consumption Comparison
4.3.1 United States VS China: Infliximab Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Infliximab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Infliximab Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Infliximab Biosimilar Production (2018-2023)
4.5 China Based Infliximab Biosimilar Manufacturers and Market Share
4.5.1 China Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Infliximab Biosimilar Production (2018-2023)
4.6 Rest of World Based Infliximab Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Infliximab Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Infliximab Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Infliximab Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CT-P13/infliximab-dyyb
5.2.2 Remsima
5.2.3 Inflectra
5.3 Market Segment by Type
5.3.1 World Infliximab Biosimilar Production by Type (2018-2029)
5.3.2 World Infliximab Biosimilar Production Value by Type (2018-2029)
5.3.3 World Infliximab Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infliximab Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Crohn's Disease
6.2.2 Rheumatoid Arthritis
6.2.3 Ulcerative Colitis
6.2.4 Ankylosing Spondylitis
6.2.5 Plaque Psoriasis
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Infliximab Biosimilar Production by Application (2018-2029)
6.3.2 World Infliximab Biosimilar Production Value by Application (2018-2029)
6.3.3 World Infliximab Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Napp Pharmaceuticals Group
7.1.1 Napp Pharmaceuticals Group Details
7.1.2 Napp Pharmaceuticals Group Major Business
7.1.3 Napp Pharmaceuticals Group Infliximab Biosimilar Product and Services
7.1.4 Napp Pharmaceuticals Group Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Napp Pharmaceuticals Group Recent Developments/Updates
7.1.6 Napp Pharmaceuticals Group Competitive Strengths & Weaknesses
7.2 Janssen Biotech
7.2.1 Janssen Biotech Details
7.2.2 Janssen Biotech Major Business
7.2.3 Janssen Biotech Infliximab Biosimilar Product and Services
7.2.4 Janssen Biotech Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Janssen Biotech Recent Developments/Updates
7.2.6 Janssen Biotech Competitive Strengths & Weaknesses
7.3 Alvogen
7.3.1 Alvogen Details
7.3.2 Alvogen Major Business
7.3.3 Alvogen Infliximab Biosimilar Product and Services
7.3.4 Alvogen Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Alvogen Recent Developments/Updates
7.3.6 Alvogen Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Infliximab Biosimilar Product and Services
7.4.4 Merck Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Celltrion
7.5.1 Celltrion Details
7.5.2 Celltrion Major Business
7.5.3 Celltrion Infliximab Biosimilar Product and Services
7.5.4 Celltrion Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Celltrion Recent Developments/Updates
7.5.6 Celltrion Competitive Strengths & Weaknesses
7.6 Pfizer(Ac Hospira)
7.6.1 Pfizer(Ac Hospira) Details
7.6.2 Pfizer(Ac Hospira) Major Business
7.6.3 Pfizer(Ac Hospira) Infliximab Biosimilar Product and Services
7.6.4 Pfizer(Ac Hospira) Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer(Ac Hospira) Recent Developments/Updates
7.6.6 Pfizer(Ac Hospira) Competitive Strengths & Weaknesses
7.7 Nippon Kayaku
7.7.1 Nippon Kayaku Details
7.7.2 Nippon Kayaku Major Business
7.7.3 Nippon Kayaku Infliximab Biosimilar Product and Services
7.7.4 Nippon Kayaku Infliximab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Nippon Kayaku Recent Developments/Updates
7.7.6 Nippon Kayaku Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Infliximab Biosimilar Industry Chain
8.2 Infliximab Biosimilar Upstream Analysis
8.2.1 Infliximab Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Infliximab Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Infliximab Biosimilar Production Mode
8.6 Infliximab Biosimilar Procurement Model
8.7 Infliximab Biosimilar Industry Sales Model and Sales Channels
8.7.1 Infliximab Biosimilar Sales Model
8.7.2 Infliximab Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Infliximab Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Infliximab Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Infliximab Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Infliximab Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Infliximab Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Infliximab Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Infliximab Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Infliximab Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Infliximab Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Infliximab Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Infliximab Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Infliximab Biosimilar Major Market Trends
Table 13. World Infliximab Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Infliximab Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Infliximab Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Infliximab Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Infliximab Biosimilar Producers in 2022
Table 18. World Infliximab Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Infliximab Biosimilar Producers in 2022
Table 20. World Infliximab Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Infliximab Biosimilar Company Evaluation Quadrant
Table 22. World Infliximab Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Infliximab Biosimilar Production Site of Key Manufacturer
Table 24. Infliximab Biosimilar Market: Company Product Type Footprint
Table 25. Infliximab Biosimilar Market: Company Product Application Footprint
Table 26. Infliximab Biosimilar Competitive Factors
Table 27. Infliximab Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Infliximab Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Infliximab Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Infliximab Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Infliximab Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 37. China Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 47. World Infliximab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Infliximab Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Infliximab Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Infliximab Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Infliximab Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Infliximab Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Infliximab Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Infliximab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Infliximab Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Infliximab Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Infliximab Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Infliximab Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Infliximab Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Infliximab Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Napp Pharmaceuticals Group Basic Information, Manufacturing Base and Competitors
Table 62. Napp Pharmaceuticals Group Major Business
Table 63. Napp Pharmaceuticals Group Infliximab Biosimilar Product and Services
Table 64. Napp Pharmaceuticals Group Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Napp Pharmaceuticals Group Recent Developments/Updates
Table 66. Napp Pharmaceuticals Group Competitive Strengths & Weaknesses
Table 67. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Janssen Biotech Major Business
Table 69. Janssen Biotech Infliximab Biosimilar Product and Services
Table 70. Janssen Biotech Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Janssen Biotech Recent Developments/Updates
Table 72. Janssen Biotech Competitive Strengths & Weaknesses
Table 73. Alvogen Basic Information, Manufacturing Base and Competitors
Table 74. Alvogen Major Business
Table 75. Alvogen Infliximab Biosimilar Product and Services
Table 76. Alvogen Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Alvogen Recent Developments/Updates
Table 78. Alvogen Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Infliximab Biosimilar Product and Services
Table 82. Merck Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Celltrion Basic Information, Manufacturing Base and Competitors
Table 86. Celltrion Major Business
Table 87. Celltrion Infliximab Biosimilar Product and Services
Table 88. Celltrion Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Celltrion Recent Developments/Updates
Table 90. Celltrion Competitive Strengths & Weaknesses
Table 91. Pfizer(Ac Hospira) Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer(Ac Hospira) Major Business
Table 93. Pfizer(Ac Hospira) Infliximab Biosimilar Product and Services
Table 94. Pfizer(Ac Hospira) Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer(Ac Hospira) Recent Developments/Updates
Table 96. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 97. Nippon Kayaku Major Business
Table 98. Nippon Kayaku Infliximab Biosimilar Product and Services
Table 99. Nippon Kayaku Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Infliximab Biosimilar Upstream (Raw Materials)
Table 101. Infliximab Biosimilar Typical Customers
Table 102. Infliximab Biosimilar Typical Distributors
Table 1. World Infliximab Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Infliximab Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Infliximab Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Infliximab Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Infliximab Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Infliximab Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Infliximab Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Infliximab Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Infliximab Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Infliximab Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Infliximab Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Infliximab Biosimilar Major Market Trends
Table 13. World Infliximab Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Infliximab Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Infliximab Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Infliximab Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Infliximab Biosimilar Producers in 2022
Table 18. World Infliximab Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Infliximab Biosimilar Producers in 2022
Table 20. World Infliximab Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Infliximab Biosimilar Company Evaluation Quadrant
Table 22. World Infliximab Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Infliximab Biosimilar Production Site of Key Manufacturer
Table 24. Infliximab Biosimilar Market: Company Product Type Footprint
Table 25. Infliximab Biosimilar Market: Company Product Application Footprint
Table 26. Infliximab Biosimilar Competitive Factors
Table 27. Infliximab Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Infliximab Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Infliximab Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Infliximab Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Infliximab Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 37. China Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Infliximab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Infliximab Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Infliximab Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Infliximab Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Infliximab Biosimilar Production Market Share (2018-2023)
Table 47. World Infliximab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Infliximab Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Infliximab Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Infliximab Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Infliximab Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Infliximab Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Infliximab Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Infliximab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Infliximab Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Infliximab Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Infliximab Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Infliximab Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Infliximab Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Infliximab Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Napp Pharmaceuticals Group Basic Information, Manufacturing Base and Competitors
Table 62. Napp Pharmaceuticals Group Major Business
Table 63. Napp Pharmaceuticals Group Infliximab Biosimilar Product and Services
Table 64. Napp Pharmaceuticals Group Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Napp Pharmaceuticals Group Recent Developments/Updates
Table 66. Napp Pharmaceuticals Group Competitive Strengths & Weaknesses
Table 67. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Janssen Biotech Major Business
Table 69. Janssen Biotech Infliximab Biosimilar Product and Services
Table 70. Janssen Biotech Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Janssen Biotech Recent Developments/Updates
Table 72. Janssen Biotech Competitive Strengths & Weaknesses
Table 73. Alvogen Basic Information, Manufacturing Base and Competitors
Table 74. Alvogen Major Business
Table 75. Alvogen Infliximab Biosimilar Product and Services
Table 76. Alvogen Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Alvogen Recent Developments/Updates
Table 78. Alvogen Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Infliximab Biosimilar Product and Services
Table 82. Merck Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Celltrion Basic Information, Manufacturing Base and Competitors
Table 86. Celltrion Major Business
Table 87. Celltrion Infliximab Biosimilar Product and Services
Table 88. Celltrion Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Celltrion Recent Developments/Updates
Table 90. Celltrion Competitive Strengths & Weaknesses
Table 91. Pfizer(Ac Hospira) Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer(Ac Hospira) Major Business
Table 93. Pfizer(Ac Hospira) Infliximab Biosimilar Product and Services
Table 94. Pfizer(Ac Hospira) Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer(Ac Hospira) Recent Developments/Updates
Table 96. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 97. Nippon Kayaku Major Business
Table 98. Nippon Kayaku Infliximab Biosimilar Product and Services
Table 99. Nippon Kayaku Infliximab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Infliximab Biosimilar Upstream (Raw Materials)
Table 101. Infliximab Biosimilar Typical Customers
Table 102. Infliximab Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Infliximab Biosimilar Picture
Figure 2. World Infliximab Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Infliximab Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Infliximab Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Infliximab Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Infliximab Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 12. Infliximab Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Infliximab Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Infliximab Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infliximab Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infliximab Biosimilar Markets in 2022
Figure 26. United States VS China: Infliximab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Infliximab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Infliximab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 32. World Infliximab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Infliximab Biosimilar Production Value Market Share by Type in 2022
Figure 34. CT-P13/infliximab-dyyb
Figure 35. Remsima
Figure 36. Inflectra
Figure 37. World Infliximab Biosimilar Production Market Share by Type (2018-2029)
Figure 38. World Infliximab Biosimilar Production Value Market Share by Type (2018-2029)
Figure 39. World Infliximab Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Infliximab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Infliximab Biosimilar Production Value Market Share by Application in 2022
Figure 42. Crohn's Disease
Figure 43. Rheumatoid Arthritis
Figure 44. Ulcerative Colitis
Figure 45. Ankylosing Spondylitis
Figure 46. Plaque Psoriasis
Figure 47. Others
Figure 48. World Infliximab Biosimilar Production Market Share by Application (2018-2029)
Figure 49. World Infliximab Biosimilar Production Value Market Share by Application (2018-2029)
Figure 50. World Infliximab Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Infliximab Biosimilar Industry Chain
Figure 52. Infliximab Biosimilar Procurement Model
Figure 53. Infliximab Biosimilar Sales Model
Figure 54. Infliximab Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Infliximab Biosimilar Picture
Figure 2. World Infliximab Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Infliximab Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Infliximab Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Infliximab Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Infliximab Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Infliximab Biosimilar Production (2018-2029) & (K Units)
Figure 12. Infliximab Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Infliximab Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Infliximab Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Infliximab Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infliximab Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infliximab Biosimilar Markets in 2022
Figure 26. United States VS China: Infliximab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Infliximab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Infliximab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Infliximab Biosimilar Production Market Share 2022
Figure 32. World Infliximab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Infliximab Biosimilar Production Value Market Share by Type in 2022
Figure 34. CT-P13/infliximab-dyyb
Figure 35. Remsima
Figure 36. Inflectra
Figure 37. World Infliximab Biosimilar Production Market Share by Type (2018-2029)
Figure 38. World Infliximab Biosimilar Production Value Market Share by Type (2018-2029)
Figure 39. World Infliximab Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Infliximab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Infliximab Biosimilar Production Value Market Share by Application in 2022
Figure 42. Crohn's Disease
Figure 43. Rheumatoid Arthritis
Figure 44. Ulcerative Colitis
Figure 45. Ankylosing Spondylitis
Figure 46. Plaque Psoriasis
Figure 47. Others
Figure 48. World Infliximab Biosimilar Production Market Share by Application (2018-2029)
Figure 49. World Infliximab Biosimilar Production Value Market Share by Application (2018-2029)
Figure 50. World Infliximab Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Infliximab Biosimilar Industry Chain
Figure 52. Infliximab Biosimilar Procurement Model
Figure 53. Infliximab Biosimilar Sales Model
Figure 54. Infliximab Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
